Download PDF
1 / Pages

Other users also viewed these articles

Changes in the intensified regimen of infliximab in patients with inflammatory bowel disease in sustained remission: Reflections on a series of cases Laura Gutiérrez-Rios; Eva Vayreda; Margalida Calafat; Fiorella Cañete; Eugeni Domènech; Míriam Mañosa;
Gastroenterol Hepatol. 2024;47:867-8
Incidence of herpes zoster in patients with inflammatory bowel disease Anna Calm; Margalida Calafat; Carlos González-Muñoza; Fiorella Cañete; Cristina Roig; Míriam Mañosa; Esther Garcia-Planella; Eugeni Domènech;
Gastroenterol Hepatol. 2024;47:598-604
Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission Gisela Piñero; Míriam Mañosa; Margalida Calafat; Eva Vayreda; Fiorella Cañete; Maria Puig; Eugeni Domènech;
Gastroenterol Hepatol. 2024;47:612-9